The crowd is buying.
The Street isn't sold. 🤔
Here's the most interesting split of the day. SPCX is trading near $165 intraday - up around 22%, with a session high of $168.75 and a record amount of stock changing hands. Yet the average Wall Street 12-month price target sits near $139, below where the stock trades right now. The crowd is piling in; the analysts, on average, are telling people to wait.
Live, intraday, ~2:30 PM ET, June 12, 2026. These are live trading figures, not a closing price - the session has not closed yet. Targets reflect a small set of early analyst notes. Editorial commentary, not investment advice.
Up ~22% intraday · session high $168.75
12-month average · range $63 to $190
The average analyst target sits roughly 15% below the live price. Put plainly: the consensus says the 12-month fair value is lower than where day-one buyers are paying.
The demand side: a record amount of stock changing hands
Start with what the crowd is doing, because it's staggering. SPCX has already turned over more than 207 million shares, with dollar volume close to $33 billion - among the heaviest debut-day turnovers the market has ever seen. On a stock with a free float of only 4.3%, that means the small pool of tradable shares is being flipped over and over by buyers who didn't get an allocation and are determined to own it now.
That frenzy is exactly why the price ran from a $150 open to a $168.75 high. It's also why the move is fragile: when a handful of shares absorbs that much demand, the price overshoots in both directions. The crowd's enthusiasm is real, but it's being expressed through the thinnest possible straw.
The supply of opinions: analysts are hedging
Now the other side. The early analyst targets are all over the map - Oppenheimer's bullish $190 at the top, a bear near $63 at the bottom - but the average lands around $139. That average being below the live price is the tell: even accounting for the wild bull case, the typical analyst thinks a ~$2.2 trillion valuation on a company at roughly 100x revenue is ahead of itself over a 12-month horizon.
The honest caveat on the caveat: it's a small set of targets on a company that's been public for hours, and 12-month estimates will move fast as real coverage builds. A $139 average today is a snapshot of caution, not a verdict.
Both can be right - just on different clocks
This isn't really a contradiction. Day-one trading is a demand event - who wants the stock, right now, at any price. A 12-month target is a value judgment - what the business is worth once the float opens up and the first earnings land. A stock can rip on demand today and still be above where the fundamentals justify for a while. That gap is the entire story of a thin-float, hyped IPO.
For now the crowd is winning the tape and the Street is winning the spreadsheet. The question that resolves it isn't today's price - it's whether SpaceX grows into the number. Watch the eventual close, the first earnings as a public company, and the lockup expiry, when far more than 4.3% of shares can finally trade and the demand-versus-value tug-of-war gets a much bigger rope.
The 60-second version
SPCX trades near $165 intraday (session high $168.75, up ~22%), but the average analyst 12-month target is around $139 - below the price.
The crowd is frantic: 207M+ shares and ~$33B traded already, among the biggest debut-day turnovers ever - on a float of just 4.3%.
Targets range wildly ($63 to $190), but the average below the price says the typical analyst sees a ~$2.2T, ~100x-revenue stock as ahead of itself.
Not a contradiction: today is a demand event, the target is a 12-month value call. The gap is the whole story of a thin-float, hyped IPO. (And no, it hasn't closed yet.)
Part of our SpaceX IPO Live Blog · the live thread: past $2 trillion intraday · the $190 bull case.
Hear the SPCX bull and bear case in plain English.
StockCar turns any ticker into an on-demand AI podcast. Add SPCX, TSLA, RKLB, or your whole watchlist and hear what's driving the biggest IPO ever - whenever you want it.
Download Free on iOS